Zdrowie i gospodarka · 02/11/2022

FDA Releases Draft Guidance on Assessing User Fees for Over-the-Counter Monograph Drug Program

The Food and Drug Administration (FDA) has released a draft guidance for industry on assessing user fees for the Over-the-Counter Monograph Drug User Fee Program, which is authorized under the Federal Food, Drug, and Cosmetic Act (FD&C Act).